Market capitalization | $858.48m |
Enterprise Value | $971.68m |
P/E (TTM) P/E ratio | 55.38 |
EV/FCF (TTM) EV/FCF | 26.55 |
EV/Sales (TTM) EV/Sales | 1.43 |
P/S ratio (TTM) P/S ratio | 1.26 |
P/B ratio (TTM) P/B ratio | 0.70 |
Revenue growth (TTM) Revenue growth | -9.12% |
Revenue (TTM) Revenue | $681.50m |
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
3 Analysts have issued a Avanos Medical, Inc. forecast:
3 Analysts have issued a Avanos Medical, Inc. forecast:
Sep '24 |
+/-
%
|
||
Revenue | 682 682 |
9%
9%
|
|
Gross Profit | 378 378 |
9%
9%
|
|
EBITDA | 108 108 |
13%
13%
|
EBIT (Operating Income) EBIT | 62 62 |
20%
20%
|
Net Profit | 16 16 |
128%
128%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Avanos Medical, Inc. is a medical technology company, which focuses on delivering clinically medical device solutions to improve patients' quality of life. Its portfolio of innovative product offerings focused on respiratory and digestive health, along with surgical and interventional pain management to improve patient outcomes and reduce the cost of care. Its brands include ON-Q, Coolife, Microcuff, MIC-Key, Quilbloc and Home pump. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.
Head office | United States |
CEO | Michael Greiner |
Employees | 3,771 |
Founded | 2014 |
Website | www.avanos.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.